Belgium
TakeAir is a Belgium-based startup with a mission to deliver revolutionary biotechnology and industry 4.0 connected services to create a health-conscious environment safe from airborne pathogens, promoting a balanced microbial climate. The company performs audits on Indoor Air Quality (IAQ) and issues certificates based on the Biospheric Index.
The flagship product, Biospheric Air Treatment, is an automated biotechnology that integrates with existing ventilation systems, supplemented with sensor technology, to capture and eliminate airborne pollution and particles, ensuring a consistently optimal indoor climate. Founded in 2016, TakeAir initially distributed beneficial organisms in ventilation ducts, leading to the development of Biospheric Air Treatment, supporting customers' ESG goals. Recent R&D efforts have resulted in the successful capturing and killing of airborne viral pathogens in ventilation ducts.
Key successes include collaborations with CBRE Investment Management and Vattenfall (Amsterdam), as well as partnerships with institutions such as Vinçotte and universities including UGent, KU Leuven, UAntwerp. The company also participated in conferences like Healthy Buildings America 2021.
TakeAir envisions becoming the leading supplier of biological and microbial technologies for the built environment, aiming to enable people to breathe healthy air in urban and extreme environments. The startup's innovative approach creates higher value for real estate owners with less environmental impact.
The startup received a Non-Equity Assistance investment on 01 July 2024 from Leading Cities, signifying confidence in its mission and potential for growth.
